NCT06888999 In Vitro Exposure by VR to Enhance Return to Work After Sick Leave Due to Mental Health Related Complaints
| NCT ID | NCT06888999 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
| Condition | Return to Work |
| Study Type | INTERVENTIONAL |
| Enrollment | 118 participants |
| Start Date | 2025-11-17 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 118 participants in total. It began in 2025-11-17 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this pilot randomised controlled trial is to investigate whether in vitro exposure by VR enhances return to work (RTW) in flight cabin crew on sick leave with mental health related complaints. The main research questions are: 1. Does VR enhances time to RTW? 2. Does VR increase self-efficacy and positive cognitions regarding RTW, and decrease job anxiety? Researchers will compare a control group receiving care as usual as provided by the occupational physician and a psychologist to an intervention group receiving care as usual plus (al least) one session with VR-glasses in which participants are virtually exposed to their workplace.
Eligibility Criteria
Inclusion Criteria: \- sick listed cabin crew with mental health related complaints that are referred by the occupational physician to a specific psychotherapist practice Exclusion Criteria: * epilepsy * vestibular disorder * no signed informed consent
Contact & Investigator
Roosmarijn M.C. Schelvis, PhD
PRINCIPAL INVESTIGATOR
Amsterdam UMC
Frequently Asked Questions
Who can join the NCT06888999 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Return to Work. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06888999 currently recruiting?
Yes, NCT06888999 is actively recruiting participants. Contact the research team at m.c.bakhuysroozeboom@amsterdamumc.nl for enrollment information.
Where is the NCT06888999 trial being conducted?
This trial is being conducted at Schiphol, Netherlands.
Who is sponsoring the NCT06888999 clinical trial?
NCT06888999 is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). The principal investigator is Roosmarijn M.C. Schelvis, PhD at Amsterdam UMC. The trial plans to enroll 118 participants.